NEW ENTERPRISE ASSOCIATES 10, L.P.

Company

GYRE THERAPEUTICS, INC.

Filed

January 28, 2008

Accession Number

0001072613-08-000191

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →